How effective and safe to give oxygen therapy in children suffering from respiratory disease who requires oxygen therapy by using a medical device named as Heated Humidified High Flow Nasal Canula (HHHFNC)
Not Applicable
- Conditions
- Health Condition 1: J219- Acute bronchiolitis, unspecifiedHealth Condition 2: J13- Pneumonia due to Streptococcus pneumoniaeHealth Condition 3: J159- Unspecified bacterial pneumonia
- Registration Number
- CTRI/2021/10/037648
- Lead Sponsor
- Chacha Nehru Bal Chikitsalaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)transcutaneous oxygen saturation (spo2) lessthan 92%at room air
2) respiratory rate more than upper limit of normal range for age
3) oxygen therapy started less than 4 hours of admission to emergency ward
Exclusion Criteria
1)Upper airway obstruction
2)children with immediate need for intubation
3) modified glassgow coma scale (GCS) lessthan 8
4)all diagnosed heart diseases
5)covid patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie HHHFNC's improved oxygenation in pediatric acute hypoxaemic respiratory failure (J219, J13, J159)?
How does HHHFNC compare to standard nasal cannula/CPAP in reducing ICU stay for children with J219, J13, J159-related respiratory failure?
Which biomarkers (e.g., inflammatory markers, oxygen saturation thresholds) predict HHHFNC response in J219/J13/J159 pediatric patients?
What adverse events are associated with HHHFNC in children with bacterial pneumonia (J13, J159) versus bronchiolitis (J219)?
Are there adjunct therapies (e.g., bronchodilators, antibiotics) that synergize with HHHFNC for J219, J13, J159 respiratory failure management?